5GWW image
Entry Detail
PDB ID:
5GWW
Title:
Structure of MoeN5-Sso7d fusion protein in complex with a permethylated substrate analogue
Biological Source:
PDB Version:
Deposition Date:
2016-09-14
Release Date:
2017-09-20
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.22
R-Value Work:
0.17
Space Group:
C 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:MoeN5,DNA-binding protein 7d
Chain IDs:A, B, C, D
Chain Length:343
Number of Molecules:4
Biological Source:Streptomyces ghanaensis, Sulfolobus solfataricus
Ligand Molecules
Primary Citation
Complex structures of MoeN5 with substrate analogues suggest sequential catalytic mechanism.
Biochem. Biophys. Res. Commun. 511 800 805 (2019)
PMID: 30837154 DOI: 10.1016/j.bbrc.2019.02.131

Abstact

The antibiotic moenomycin A is a phosphoglycerate derivative with a C25-moenocinyl chain and a branched oligosaccharide. Formation of the C25-chain is catalyzed by the enzyme MoeN5 with geranyl pyrophosphate (GPP) and the sugar-linked 2-Z,E-farnesyl-3-phosphoglycerate (FPG) as its substrates. Previous complex crystal structures with GPP and long-chain alkyl glycosides suggested that GPP binds to the S1 site in a similar way as in most other α-helical prenyltransferases (PTs), and FPG is likely to assume a bent conformation in the S2 site. However, two FPG derivatives synthesized in the current study were found in the S1 site rather than S2 in their complex crystal structures with MoeN5. Apparently S1 is the preferred site for prenyl-containing ligand, and S2 binding may proceed only after S1 is occupied. Thus, like most trans-type PTs, MoeN5 may employ a sequential ionization-condensation-elimination mechanism that involves a carbocation intermediate.

Legend

Protein

Chemical

Disease

Primary Citation of related structures